Ayalew Tefferi
Impact in
- Genetics top 0.01%
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Chronic Lymphocytic Leukemia Research
- Hematology top 0.01%
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
Papers in
- Genetics 852
- Myeloproliferative Neoplasms: Diagnosis and Treatment 748
- Chronic Lymphocytic Leukemia Research 95
- Hemoglobinopathies and Related Disorders 79
- Hematology 728
- Acute Myeloid Leukemia Research 441
- Chronic Myeloid Leukemia Treatments 317
- Multiple Myeloma Research and Treatments 74
- Co-authors
- Animesh Pardanani (251 shared papers)Terra L. Lasho (215 shared papers)Ruben A. Mesa (136 shared papers)Curtis A. Hanson (206 shared papers)Naseema Gangat (251 shared papers)Christy M. Finke (148 shared papers)Mrinal M. Patnaik (183 shared papers)Alessandro M. Vannucchi (104 shared papers)
- Journals
- Blood (326 papers)American Journal of Hematology (159 papers)Mayo Clinic Proceedings (83 papers)Leukemia (69 papers)British Journal of Haematology (47 papers)
- Partner nations
- United StatesItalyGermany
In The Last Decade
Ayalew Tefferi
1.1k papers receiving 55.9k citations
Ayalew Tefferi's Hit Papers
Peers
Comparison fields: 5 of 181
- Genetics 38.5k
- Hematology 31.8k
- Rheumatology 14.1k
- Molecular Biology 19.1k
- Immunology 5.6k
Countries citing papers authored by Ayalew Tefferi
This map shows the geographic impact of Ayalew Tefferi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ayalew Tefferi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ayalew Tefferi more than expected).
Fields of papers citing papers by Ayalew Tefferi
This network shows the impact of papers produced by Ayalew Tefferi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ayalew Tefferi. The network helps show where Ayalew Tefferi may publish in the future.
Co-authors
The 25 scholars most cited alongside Ayalew Tefferi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 1.1k papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes Hit paper breakdown → | 2009 | 3153 |
| 2 | Safety and Efficacy of INCB018424, a JAK1 and JAK2 Inhibitor, in Myelofibrosis Hit paper breakdown → | 2010 | 868 |
| 3 | New prognostic scoring system for primary myelofibrosis based on a study of the International Working Group for Myelofibrosis Research and Treatment Hit paper breakdown → | 2008 | 856 |
| 4 | MPL515 mutations in myeloproliferative and other myeloid disorders: a study of 1182 patients Hit paper breakdown → | 2006 | 798 |
| 5 | Classification and diagnosis of myeloproliferative neoplasms: The 2008 World Health Organization criteria and point-of-care diagnostic algorithms Hit paper breakdown → | 2007 | 689 |
| 6 | DIPSS Plus: A Refined Dynamic International Prognostic Scoring System for Primary Myelofibrosis That Incorporates Prognostic Information From Karyotype, Platelet Count, and Transfusion Status Hit paper breakdown → | 2010 | 686 |
| 7 | A dynamic prognostic model to predict survival in primary myelofibrosis: a study by the IWG-MRT (International Working Group for Myeloproliferative Neoplasms Research and Treatment) Hit paper breakdown → | 2009 | 650 |
| 8 | Proposals and rationale for revision of the World Health Organization diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis: recommendations from an ad hoc international expert panel Hit paper breakdown → | 2007 | 624 |
| 9 | Myelofibrosis with Myeloid Metaplasia Hit paper breakdown → | 2000 | 580 |
| 10 | Long-term survival and blast transformation in molecularly annotated essential thrombocythemia, polycythemia vera, and myelofibrosis Hit paper breakdown → | 2014 | 513 |
| 11 | Myelodysplastic Syndromes Hit paper breakdown → | 2009 | 507 |
| 12 | Circulating Interleukin (IL)-8, IL-2R, IL-12, and IL-15 Levels Are Independently Prognostic in Primary Myelofibrosis: A Comprehensive Cytokine Profiling Study Hit paper breakdown → | 2011 | 443 |
| 13 | 2007 | 430 | |
| 14 | 2012 | 413 | |
| 15 | The 2016 WHO classification and diagnostic criteria for myeloproliferative neoplasms: document summary and in-depth discussion Hit paper breakdown → | 2018 | 403 |
| 16 | 2010 | 385 | |
| 17 | 2009 | 384 | |
| 18 | CALR vs JAK2 vs MPL-mutated or triple-negative myelofibrosis: clinical, cytogenetic and molecular comparisons Hit paper breakdown → | 2014 | 380 |
| 19 | 2005 | 357 | |
| 20 | Safety and Efficacy of Fedratinib in Patients With Primary or Secondary Myelofibrosis Hit paper breakdown → | 2015 | 352 |
About Ayalew Tefferi
Ayalew Tefferi is a scholar working on Genetics, Hematology, Molecular Biology, Rheumatology and Immunology, having authored 1.1k papers that have together received 57.8k indexed citations. Recurring topics across this work include Myeloproliferative Neoplasms: Diagnosis and Treatment (748 papers), Acute Myeloid Leukemia Research (441 papers), Chronic Myeloid Leukemia Treatments (317 papers), Eosinophilic Disorders and Syndromes (238 papers), Kruppel-like factors research (183 papers), Chronic Lymphocytic Leukemia Research (95 papers), Hemoglobinopathies and Related Disorders (79 papers) and Multiple Myeloma Research and Treatments (74 papers). The work is most often cited by research in Genetics (38.5k citations), Hematology (31.8k citations), Rheumatology (14.1k citations), Molecular Biology (19.1k citations) and Immunology (5.6k citations). Ayalew Tefferi has collaborated with scholars based in United States, Italy and Germany. Frequent co-authors include Animesh Pardanani, Terra L. Lasho, Ruben A. Mesa, Curtis A. Hanson, Naseema Gangat, Christy M. Finke, Mrinal M. Patnaik, Alessandro M. Vannucchi, Tiziano Barbui and James W. Vardiman. Their work appears in journals such as Blood, American Journal of Hematology, Mayo Clinic Proceedings, Leukemia and British Journal of Haematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.